GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipum AB (OSTO:LIPUM) » Definitions » EV-to-EBITDA

Lipum AB (OSTO:LIPUM) EV-to-EBITDA : -7.69 (As of May. 24, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Lipum AB EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Lipum AB's enterprise value is kr127.30 Mil. Lipum AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was kr-16.54 Mil. Therefore, Lipum AB's EV-to-EBITDA for today is -7.69.

The historical rank and industry rank for Lipum AB's EV-to-EBITDA or its related term are showing as below:

OSTO:LIPUM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -8.27   Med: 0   Max: 0
Current: -7.7

OSTO:LIPUM's EV-to-EBITDA is ranked worse than
100% of 446 companies
in the Biotechnology industry
Industry Median: 10.33 vs OSTO:LIPUM: -7.70

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-24), Lipum AB's stock price is kr6.40. Lipum AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was kr-2.003. Therefore, Lipum AB's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Lipum AB EV-to-EBITDA Historical Data

The historical data trend for Lipum AB's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipum AB EV-to-EBITDA Chart

Lipum AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
- - -0.92 -1.99 -1.41

Lipum AB Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.29 -1.99 -1.75 -3.47 -1.41

Competitive Comparison of Lipum AB's EV-to-EBITDA

For the Biotechnology subindustry, Lipum AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lipum AB's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lipum AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Lipum AB's EV-to-EBITDA falls into.



Lipum AB EV-to-EBITDA Calculation

Lipum AB's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=127.295/-16.543
=-7.69

Lipum AB's current Enterprise Value is kr127.30 Mil.
Lipum AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-16.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lipum AB  (OSTO:LIPUM) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Lipum AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=6.40/-2.003
=At Loss

Lipum AB's share price for today is kr6.40.
Lipum AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-2.003.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Lipum AB EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Lipum AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Lipum AB (OSTO:LIPUM) Business Description

Traded in Other Exchanges
N/A
Address
Tvistevagen 48 C, Umea, SWE, 907 36
Lipum AB is a clinical-stage biopharmaceutical company specializing in the discovery and development of a novel treatment for chronic inflammatory diseases. The candidate SOL-116 is a humanized antibody designed to provide efficacious therapy by blocking a previously overlooked target molecule (BSSL) of the immune system. The development is supported by solid pre-clinical data for rheumatoid arthritis. Lipum also explores other inflammatory diseases with a high unmet medical need.

Lipum AB (OSTO:LIPUM) Headlines

No Headlines